We would like to congratulate the winners of this year’s Investigator Award. The chosen winners have presented their work at the 4th EAN Congress in Lisbon this June. The Investigator Award consists of a free registration to the 5th EAN Congress in Oslo 2019 and an award certificate.
Please find below the list of winners and their presentation titles:
Anne Hege Aamodt, Oslo, NORWAY
O204 Effect and safety of tenecteplase in stroke patients with atrial fibrillation
Samiah Al-Zaidy, Columbus, UNITED STATES OF AMERICA
O317 AVXS-101 Phase 1 Gene Replacement Therapy Clinical Trial in SMA Type 1: Continued Event Free Survival and Achievement of Developmental Milestones
Josef Bednarik, Brno, CZECH REPUBLIC
O120 Corneal confocal microscopy and skin biopsy in the evaluation of diabetic small fiber neuropathy
Mina Cobeljic, Belgrade, SERBIA
EPR1163 Influence of diabetes mellitus on chronic inflammatory demyelinating polyradiculoneuropathy
Teresa Coelho, Porto, PORTUGAL
O309 Validity and Reliability of the Transthyretin Amyloidosis Neuropathy Score (TTR-ANS), a new outcome measure designed specifically for Familial Amyloid Polyneuropathy (TTR-FAP)
Jean-Charles Deybach, , FRANCE
O101 EXPLORE: A Prospective, Multinational Natural History Study of Patients With Acute Hepatic Porphyria With Recurrent Attacks
Antonin Dréan, Paris, FRANCE
O213 Increased efficacy of carboplatin after blood-brain barrier opening using low intensity pulsed ultrasound in preclinical models of glioblastoma.
Erika Driver-Dunckley, Scottsdale, UNITED STATES OF AMERICA
O111 Brain Lewy body density is associated with a lower prevalence of atherosclerotic cardiovascular disease risk factors in patients with Parkinson’s disease
Delia Gagliardi, Milan, ITALY
O318 Integrated miRNAs analysis of ALS iPSCs and iPSCs-derived motor neurons towards the development of a molecular therapy for ALS
Giuliana Galassi, Modena, ITALY
O122 Cryoglobulinaemia-associated peripheral neuropathies: clinical characteristics and prognosis from 20-years experience of Neuromuscular clinic
Pawel Kermer, Sande, GERMANY
O202 Idarucizumab in Cerebral Ischemia or Intracranial Hemorrhage under Dabigatran therapy in Germany – A Nationwide Case Collection
Merel Koopmans, Amsterdam, NETHERLANDS
O410 Characterization of a Listeria monocytogenes meningitis mouse model
James Lilleker, Salford, UNITED KINGDOM
O414 Quantifying muscle amyloid content in inclusion body myositis using [18f]florbetapir positron emission tomography
Marion Moseby Knappe, Lund, SWEDEN
O219 Predicting long-term neurological outcome after cardiac arrest with serum neurofilament light chain
Davide Pareyson, Milan, ITALY
O121 Charcot-Marie-Tooth disease type 4B with myelin outfoldings (CMT4B): a multicentre retrospective study
Patrice Péran, Toulouse, FRANCEO112 Multimodal MRI markers modifications in multiple system atrophy: a longitudinal study
Maria Assunta Rocca, Milan, ITALY
O323 Reduced dynamism of functional connectivity is associated with cognitive impairment in multiple sclerosis patients: a dynamic functional connectivity study in a multi-center setting
Rita Rodrigues, Feira, PORTUGAL
O307 Peripheral neuropathy in the context of systemic vasculitis and other autoimmune diseases: the importance of etiologic characterization
Felix Thomas, Zürich, SWITZERLAND
EPR3153 Efficacy and Feasibility of Home-Based Cooperative Hand Movement Training in Chronic Stroke Patients
Andreas Zwergal, Munich, GERMANY
O327 Persistent allocentric navigation deficits indicate hippocampal damage in transient global amnesia
